Low fat-containing elemental formula is effective for postoperative recovery and potentially useful for preventing chyle leak during postoperative early enteral nutrition after esophagectomy  by Moro, Kazuki et al.
lable at ScienceDirect
Clinical Nutrition 35 (2016) 1423e1428Contents lists avaiClinical Nutrition
journal homepage: ht tp: / /www.elsevier .com/locate/c lnuOriginal articleLow fat-containing elemental formula is effective for postoperative
recovery and potentially useful for preventing chyle leak during
postoperative early enteral nutrition after esophagectomy
Kazuki Moro a, Yu Koyama b, *, Shin-ichi Kosugi c, Takashi Ishikawa a, Hiroshi Ichikawa a,
Takaaki Hanyu a, Kohei Miura a, Masayuki Nagahashi a, Masato Nakajima a,
Kumiko Tatsuda a, Junko Tsuchida a, Chie Toshikawa a, Mayuko Ikarashi a,
Yoshifumi Shimada a, Jun Sakata a, Takashi Kobayashi a, Hitoshi Kameyama a,
Toshifumi Wakai a
a Division of Digestive & General Surgery, Niigata University Graduate School of Medical & Dental Sciences, 1-757 Asahimachi, Niigata, Niigata 951-8510,
Japan
b Department of Nursing, Niigata University Graduate School of Health Sciences, 2-746 Asahimachi, Niigata, Niigata 951-8518, Japan
c Department of Digestive and General Surgery, Uonuma Institute of Community Medicine, Niigata University Medical and Dental Hospital, 4132 Urasa,
Minami-Uonuma, Niigata, Japana r t i c l e i n f o
Article history:
Received 3 November 2015
Accepted 23 March 2016
Keywords:
Chyle leak
Early enteral nutrition
Esophageal cancer
Low fat-containing elemental formula
Thoracic ductAbbreviations: TTE-3FL, Transthoracic esophagect
nectomy; EN, enteral nutrition; TPN, total parenter
triglycerides; SIRS, systematic inﬂammatory respons
assisted thoracoscopic esophagectomy; MCT, midd
forced expiratory volume in one second.
* Corresponding author. Tel./fax: þ81 25 227 2361.
E-mail address: yukmy@clg.niigata-u.ac.jp (Y. Koya
http://dx.doi.org/10.1016/j.clnu.2016.03.018
0261-5614/© 2016 The Authors. Published by Elseviers u m m a r y
Background and aims: Transthoracic esophagectomy using 3-ﬁeld lymphadenectomy (TTE-3FL) for
esophageal cancer is one of the most aggressive gastrointestinal surgeries. Early enteral nutrition (EN) for
TTE-3FL patients is useful and valid for early recovery; however, EN using a fat-containing formula risks
inducing chyle leak. In the present study, we retrospectively examined esophageal cancer patients
treated byTTE-3FL and administered postoperative EN to elucidate the validity of lowering the fat levels
in elemental formulas to prevent postoperative chyle leak and improve postoperative recovery.
Methods: A total of 74 patients who received TTE-3FL for esophageal cancer were retrospectively exam-
ined. Patients were classiﬁed into two groups according to the type of postoperative EN: Group LF patients
received a low-fat elemental formula, and Group F patients received a standard fat-containing polymeric
formula. The following clinical factors were compared between the groups: EN start day, maximum EN
calories administered, duration of respirator use, length of ICU stay, incidence of postoperative infectious
complications, use of parenteral nutrition (PN), and incidence of postoperative chyle leak.
Results: Patients in Group LF were started on EN signiﬁcantly earlier after surgery and they consumed
signiﬁcantly higher maximum EN calories compared to Group F patients (P < 0.01). Duration of respirator
use and length of ICU stay were also signiﬁcantly shorter, and TPN was used signiﬁcantly less in Group LF
compared to Group F (P < 0.05). Postoperative chyle leak was observed in six patients in total (8.1%); ﬁve
patients in Group F and one patient in Group LF, although there was no signiﬁcant difference in frequency
of chyle leak per patient between Group LF and Group F.
Conclusions: Early EN using low-fat elemental formula after esophagectomy with three-ﬁeld lympha-
denectomy was safe and valid for postoperative recovery and potentially useful in preventing chyle leak.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).omy with 3-ﬁeld lymphade-
al nutrition; LCT, long chain
e syndrome; VATs-E, video-
le-chain triglycerides; FEV1,
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Ltd. This is an open access article u1. Introduction
Chyle leak such as chylous ascites or chylothorax is a rare
complication after esophagectomy, having a reported incidence of
0.6e10% [1e6]. It can lead to hypovolemia, infection, metabolic and
nutritional depletion, and more than 50% mortality if untreated [7].
Transthoracic esophagectomy accompanied by 3-ﬁeldnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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cedures among digestive surgeries. Postoperative administration of
early enteral nutrition (EN) is useful and valid for aiding early re-
covery in patients undergoingTTE-3FL [8,9]. However, because the
fat contained in standard EN formula, and especially long-chain
triglycerides (LCT), is generally transported from intestinal cells as
chylomicron via the intestinal lymphatic ducts [10], early EN using
such formula after TTE-3FLmay induce the risk of chyle leak such as
chylothorax or chylous ascites. In fact, restricting or eliminating oral
and enteral fat intake can reduce chyle ﬂow, and total elimination
of fat intake is one of the conservative treatments for chylothorax
[10]. Therefore, EN using a low-fat formula might reduce the risk of
chyle leak and thus improve early recovery following TTE-3FL.
In the present study, we retrospectively examined esophageal
cancer patients who underwent TTE-3FL and who also received
postoperative EN. Our aim was to clarify whether using low-fat
elemental formula could more effectively prevent postoperative
chyle leak and improve postoperative recovery compared to stan-
dard fat-containing formula.
2. Materials and methods
2.1. Selection of patients
Esophageal cancer patients who underwent TTE-3FL at Niigata
University Medical and Dental Hospital from 2002 to 2014 were
enrolled in this study, which comprised a retrospective analysis by
chart review. In total, 74 patients were selected for analysis
following approval from the Institutional Review Board for Clinical
Research. Our department currently has no systematic protocol in
place for the starting sequence for EN or for choosing the EN for-
mula, thus these factors are individually decided according to each
patient's condition and the clinical experience of their doctor.
Postoperative EN is generally administered in our department for
patients undergoing jejunostomy performed simultaneously with
esophageal surgery. In this study, patients were retrospectively
divided into two groups based on the EN formula administered:
Group F contained the patients who started EN with a standard fat-
containing polymeric formula (ENSURE LIQUID®; Abbott Japan Co.,
Ltd., Tokyo, Japan [11], RACOL®; Ohtsuka Chemical Industrial Co.,
Ltd., Tokushima, Japan [12], or IMPACT®, Ajimonoto Co., Inc., Tokyo,
Japan [13]); and Group LF contained the patients who started EN
with a low-fat elemental formula (ELENTAL®; Ajimonoto Pharma-
ceuticals Co., Ltd., Tokyo, Japan [14]). Each EN formula provides
energy as 1 kcal/ml, and the composition of carbohydrate, protein
or amino acid, and fat are detailed in Table 1.
The starting dose of EN comprised 200e300 ml of elemental or
polymeric formula administered at 20e25 ml/h from surgically
placed jejunostomy. The dose was increased gradually, every
12e24 h, to a maximum dose on day 5e6 of EN administration if
there were no related problems in either group.
In Group LF, the low-fat formulawas converted to a standard fat-
containing polymeric formula according to the decrease in drain
ﬂuid volume. Both groups of patients also received intravenous
infusions of electrolytes and 4.3% glucose solution to retainTable 1
Composition of carbohydrate, protein (amino acid), and fat in each enteral formula.
Fat-containing polymeric formula
ENSURE® RACOL®
Carbohydrate 13.7 15.6
Protein (amino acid) 3.5 4.4
Fat 3.5 2.2
Each value was expressed as g/100 kcal; ELENTAL was composed of free amino acid as aadequate water and electrolyte levels. Supplemental parenteral
nutrition (SPN) was also chosen on a patient-by-patient basis, and
is deﬁned in this study as an infusion containing amino acids and
glucose. Each patient's doctors chose the date of EN conversion,
choice of standard fat-containing polymeric formula, and usage of
supplemental parenteral nutrition (SPN) on an individual basis.
Total parenteral nutrition (TPN) was introduced when EN could not
be started at day 5 after surgery.2.2. Clinical assessment
We compared Groups F and LF according to the follows clinical
factors: age, gender, cancer stage according to the classiﬁcation of
tumor-node-metastasis deﬁned by the International Union Against
Cancer (6th edition), EN start day, maximum EN calories adminis-
tered per day, recovery of bowel movement deﬁned as ﬁrst stool
passage date, perioperative change in serum albumin and total
cholesterol, length of ICU stay, duration of respirator use, duration
of systematic inﬂammatory response syndrome (SIRS), and use of
SPN and/or TPN. Diagnosis of SIRS followed the criteria of the ACCP-
SCCM Consensus Conference Committee [15], with at least two of
the following criteria required for a diagnosis: respiratory rate >20/
min or peripheral arterial CO2 tension (PaCO2) <32 mmHg, tachy-
cardia >90/min, systolic blood pressure <90 mmHg, leukocytosis
>12,000/ml or leukopenia <4000/ml or 10% of immature leukocyte
forms, and body temperature >38.0 C or <36.0 C.
Patient records were reviewed retrospectively to establish the
incidence of postoperative complications. Incidence of post-
operative complications, recurrent nerve palsy, infectious compli-
cations, and chyle leak were compared between groups. For
detection of recurrent nerve palsy, deﬁned as the failure of vocal
cord function with/without hoarseness, postoperative lar-
yngoﬁberscopy was performed in all patients in this study, as
previously described [16]. Presence of accompanying infection such
as wound infection, pneumonia, and/or sepsis was deﬁned as an
infectious complication in this study. The diagnosis of chyle leak
was made clinically after observation of a milky drain ﬂuid or by
cytological examination to prove the existence of fat droplets in the
drain ﬂuid was not milky, but exceeded 500 ml/day.2.3. Statistics
The statistical comparisons were performed using Man-
neWhitney U test, adjusted Chi-square test, and two-way analysis
of variance (ANOVA). The Exact Chi-square test was used when
there were fewer than 5 cells. The statistical signiﬁcance was
deﬁned as a P-value <0.05.3. Results
3.1. Perioperative features
Of the 74 enrolled patients, 53 patients were classiﬁed into
Group F, and 21 into Group LF (Table 2).Low-fat elemental formula
IMPACT® ELENTAL®
13.2 21.1
5.5 4.4
2.8 0.17
nitrogen source.
Table 2
Pre- and perioperative clinical Features: Group F versus Group LF.
Total (74 pts) Group F (53 pts) Group LF (21 pts) P
Age (years)a 61.9 ± 7.3 61.1 ± 6.8 64.0 ± 8.4 0.153
BMI (kg/m2)a 21.5 ± 2.9 21.4 ± 3.2 22.0 ± 2.3 0.372
Albumin (g/dl)a 4.1 ± 0.4 4.0 ± 0.4 4.1 ± 0.4 0.474
Total Cholesterol (mg/dl)a 196 ± 41 191 ± 39 207 ± 45 0.254
Surgery time (min)a 487 ± 91 471 ± 76 528 ± 113 0.021
Blood loss (ml)a 618 ± 307 647 ± 284 542 ± 357 0.143
Gender 0.416
Male 64 45 19
Female 10 8 2
Stage 0.278
0 2 2 0
I 23 15 8
II 15 12 3
III 23 14 9
IV 11 10 1
Preoperative chemotherapy 0.798
No 38 28 10
Yes 36 25 11
Postoperative SPN use <0.001
No 25 9 16
Yes 49 44 5
Postoperative TPN use 0.007
No 60 39 21
Yes 14 14 0
a Data are mean ± standard deviation; pts: patients; BMI: body metabolic rate; SPN: supplemental parenteral nutrition; TPN: total parenteral nutrition.
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distribution of cancer stage, preoperative nutritional status based
on body mass index (BMI), levels of serum albumin and total
cholesterol, and the status of preoperative chemotherapy. Post-
operative SPN and TPN were used more frequently in Group F than
in Group LF (P < 0.01).
3.2. Postoperative outcomes comparing low fat-containing formula
with standard fat-containing formula
In Group LF, the low-fat elemental formula was converted to
standard fat-containing polymeric formula after a median duration
of 5 days (range from day 3 to day 11). The date of postoperative EN
(day) was signiﬁcantly earlier (1.0 vs. 2.6; P < 0.01) and supply of
postoperative maximum EN calorie (kcal/kg) was signiﬁcantly
higher in Group LF than in Group F (32.9 vs. 28.0; P < 0.01) (Table 3).
Recovery of bowel movement and the duration of SIRS were com-
parable between the groups; however, the length of respirator
management (day) was signiﬁcantly shorter (1.7 vs. 3.3; P < 0.05)
and the length of ICU stay (day) was signiﬁcantly shorter in Group
LF compared with Group F (3.0 vs. 3.8; P < 0.05).
On nutritional status, postoperative body weight loss, periop-
erative change of serum albumin, and total cholesterol were com-
parable between the groups (Fig. 1).
3.3. Postoperative complications
Among a total of 74 patients, 61 patients (82.4%) experienced
postoperative complications; however, no signiﬁcant differenceTable 3
Postoperative outcomes: Group F versus Group LF.
Total (74 pts) G
EN start (day)a 2.1 ± 1.6
Maximum EN calorie (kcal/kg)a 29.4 ± 7.9
BW loss (%)a 8.9 ± 15.9 
First stool passage (day)a 6.0 ± 2.6
SIRS duration (day)a 4.6 ± 5.0
ICU stay (day)a 3.6 ± 2.6
Respirator duration (day)a 2.8 ± 5.8
a Data are mean ± standard deviation; pts: patients; EN: enteral nutrition; BW: body wwas observed in the analysis of complications between Group LF
and Group F. While both groups showed a moderately high inci-
dence of recurrent nerve palsy, it was subclinical and transient in
the majority of patients. No signiﬁcant difference was observed
between groups in infectious complications, although Group LF
showed signiﬁcant more pneumonia than Group F (P < 0.05)
(Table 4).3.4. Postoperative chyle leak
Postoperative chyle leak was observed in 6 patients (8.1%): 5
patients (4 chylothorax and 1 chylous ascites) in Group F and 1
patient (chylothorax) in Group LF (Table 4). In terms of the surgical
procedure, open radical thoracic esophagectomy (ORE) was con-
ducted in 54 patients (45 patients in Group F, 9 patients in Group
LF) and video-assisted thoracoscopic esophagectomy (VATs-E) was
carried out in 20 patients (8 patients in Group F, 12 patients in
Group LF). Although VATs-E was performed more frequently in
Group LF compared to Group F (P < 0.01), the incidence of chyle
leak was comparable between patients undergoing ORE and VATs-E
(Table 5).
Thoracic duct ligation/resection was performed in 53 patients,
with signiﬁcantly more cases from Group LF than Group F
(P < 0.01), although, again, the frequency of chyle leak was equiv-
alent among all patients with or without thoracic duct ligation
(Table 6).
The median start date of chyle leak was on postoperative day 4
(range from day 2 to day 7). Interestingly, while there was noroup F (53 pts) Group LF (21 pts) P
2.6 ± 1.6 1.0 ± 0.4 <0.001
28.0 ± 8.3 32.9 ± 5.6 0.001
10.2 ± 18.6 5.7 ± 3.7 0.309
5.5 ± 1.6 7.0 ± 4.0 0.131
4.0 ± 4.9 5.9 ± 5.1 0.055
3.8 ± 2.6 3.0 ± 2.8 0.014
3.3 ± 6.7 1.7 ± 2.3 0.017
eight; SIRS: systematic inﬂammatory response syndrome; ICU: intensive care unit.
Fig. 1. Perioperative changes in serum albumin (A) and total cholesterol (B) in Group F and Group LF.
Table 4
Postoperative complication and mortality: Group F versus Group LF.
Total (74 pts) Group F (53 pts) Group LF (21 pts) P
Postoperative
complications
61 41 20 0.094
Recurrent
nerve palsy
36 25 11 0.798
Infectious 44 28 16 0.073
Pneumonia 19 10 9 0.042
Wound infection 20 14 7 0.057
Sepsis 6 4 2 >0.999
Chyle leak 6 5 1 0.668
Mortality 1 1 0 >0.999
pts: patients.
Table 5
Relationship between surgical procedure and EN formula or chyle leak.
Total
(74 pts)
Open radical
esophagectomy (54 pts)
VATs-E
(20 pts))
P
EN group 0.001
Group F 53 45 8
Group LF 21 9 12
Chyle leak >0.999
Negative 68 49 19
Positive 6 5 1
pts: patients; VATs-E: video-assisted thoracic esophagectomy; EN: enteral nutrition.
Table 6
Relationship between thoracic duct preparation and EN formula or chyle leak.
Total
(74 pts)
Thoracic duct preparation P
Resected/ligated
(53 pts)
Preserved
(21 pts)
EN group <0.001
Group F 53 46 7
Group LF 21 7 14
Chyle leak 0.449
Negative 68 48 20
Positive 6 5 1
pts: patients; EN: enteral nutrition.
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groups, it occurred in Group LF patients after changing from the
low-fat EN formula to a fat-containing polymeric formula. Conse-
quently, postoperative chyle leak was observed in 6 patients onlywhen receiving the fat-containing polymeric formula, regardless of
the starting formula.
In terms of perioperative mortality, only one patient in Group F
died, occurring on postoperative day 8 due to aortic rupture. Mor-
tality was comparable between the groups (Table 4).4. Discussion
Chyle leak, represented by chylothorax, generally occurs as a
complication of major thoraco-abdominal surgery and is caused by
surgical trauma or damage to the thoracic duct, cysterna chyli.
Esophageal surgery is probably the most common iatrogenic cause
of chylothorax. The 8.1% rate of chyle leak observed in our series (6
patients: 5 patients of chylothorax and 1 patient of chylous ascites)
coincides with the result of previous reports, at 0.6e10% [1e6]. In
the present study, we set an object in TTE-3FL for esophageal
cancer, because this surgery is more radical and invasive compared
with transhiatal esophagectomy, therefore chyle leak might be
more common after transthoracic compared with transhiatal
esophagectomy [17].
Two different surgical approaches for esophagectomy were
introduced in our study; standard open radical esophagectomy for
54 patients and VATs-E for 20 patients. While signiﬁcantly more
patients in Group LF underwent VATs-E than in Group F, the fre-
quency of chyle leak was comparable across the two approaches.
As a result, the incidence of chyle leak was lower in Group LF
compared to Group F, and seemed to be unaffected by the surgical
approach selected. We experienced one case of chylothorax among
20 VATs-E cases, and the thoracic duct was preserved in this case.
Prophylactic ligation of the thoracic duct during VATs-E has
proven effective previously in preventing postoperative chyle leak
[6]. However, there was no signiﬁcant difference in chyle leak with
or without ligation of thoracic duct during VATs-E in the present
study (data not shown). Ligation/resection of thoracic duct was
carried out in 71.6% of cases during TTE-3FL as part of a radical
dissection procedure and was performed signiﬁcantly more
frequently in Group LF; however, the incidence of chyle leak was
equivalent with or without thoracic duct resection/ligation.
Therefore, the apparently lower incidence of chyle leak in Group
LF seemed unaffected by the thoracic duct resection/ligation
procedure.
Early EN after TTE-3FL using a fat-containing formula is reported
to increase the risk of chyle leak. Chyle is abundantly composed of
triglycerides contained in chylomicrons, which is absorbed from
K. Moro et al. / Clinical Nutrition 35 (2016) 1423e1428 1427the intestine-associated lymphatic system, transported via the
thoracic duct, and ﬁnally supplied to the blood stream [18,19].
Because chylomicrons comprise mainly LCT, and LCT is the major
component of dietary fat or fat-containing enteral formula, limiting
or deleting enteral LCT administration is effective management for
postoperative chyle leak. Nevertheless, use of TPN [20,21] or EN
containing middle-chain triglycerides (MCT) [19,22] has been re-
ported as a conservative management for postoperative chyle leak.
The low-fat elemental formula, ELENTAL® (Ajimonoto Pharma-
ceuticals CO., LTD., Tokyo, Japan) was recently recommended for
the management of postoperative chyle leak [23]. ELENTAL® con-
sists of 15% protein, 83.5% carbohydrate, and 1.5% fat as caloric
distribution, and can provide nearly fat-free EN. The formula of
ELENTAL® is almost identical to that of VIVONEX® T.E.N. (Nestle
Health Science) [24], marketed inmanyWestern countries, and also
was recommended for conservative treatment of postoperative
chyle leak to achieve complete recovery [23,25,26]. Moreover, there
have been several reports on the management of chyle leak.
However, few reports consider the prevention of postoperative
chyle leak while performing enteral nutrition, as we have tried to
address herein.
In the present study, chyle leak was observed in one patient of
Group LF; however, it occurred only after changing EN from the low
fat to standard fat. One case of chyle leak in Group LF also occurred
on day 7 after the EN conversion on day 5; however, the median
date of chyle leak appearance was postoperative day 4 and the
median date of conversion of EN from low-fat formula to standard
fat-containing polymeric formula was on day 5. Therefore, the
conversion date in our study seemed to be almost appropriate.
Our results showed that the date of postoperative EN (day) for
Group LF was signiﬁcantly earlier than that for Group F, possibly
due to an historical bias in EN starting date, i.e., the patients
treated during 2002e2005 were included in Group F and expe-
rienced a signiﬁcantly later average EN starting date that patients
treated during 2006e2014 (average EN starting date 2002e2005
vs. 2006e2014: 3.2 days vs. 1.2 days, P < 0.01). Although our re-
sults also showed earlier recovery in Group LF, based on a shorter
ICU stay and length of respirator management, the data might be
inﬂuenced by the earlier EN start in Group LF rather than by the
formula composition. Nevertheless, the low-fat elemental formula
was at least equivalent to the standard fat-containing polymeric
formula in nutritional effect, as shown by the body weight loss
and perioperative changes in serum albumin and total cholesterol.
In addition, SPN was used more frequently in Group F than in
Group LF, although in the cases of SPN use, no signiﬁcant differ-
ence was observed between Group F and Group LF in the start day
of SPN (1.6 ± 0.9 day vs. 1.4 ± 0.5 day) or initial calorie intake with
SPN (754 ± 232 kcal vs. 672 ± 274 kcal). While the use of SPN could
have negatively affected postoperative nutritional status in this
study, we cannot explain such a phenomenon at present. Fre-
quency of postoperative complications was comparable between
Group LF and Group F except for pneumonia. A previous study
showed that early EN start after esophagectomy or pan-
creatoduodenectomy resulted in impaired respiratory mechanics,
indicated by signiﬁcantly lower forced expiratory volume in 1 s
(FEV1), and vital capacity compared with controls [27]. Therefore,
the early EN start in Group LF of this study might also have led to
impaired respiratory function such as decreased vital capacity
and/or FEV1, and thus to the high frequency of postoperative
pneumonia.
The main limitations of the present study include its retro-
spective design and that we could not assign signiﬁcant superi-
ority to the low-fat elemental formula with respect to frequency
of chyle leak compared to the fat-containing formula. The failure
to indicate signiﬁcant difference might reﬂect an insufﬁcientnumber of patients, and approximately eight times the number of
patients that we analyzed would be necessary to obtain statistical
signiﬁcance in such a comparison. However, encountering more
than 500 cases of esophagectomy would take a long time,
therefore, we present our current results without statistical sig-
niﬁcance on the frequency of chyle leak. Moreover, because this
study was not a randomized trial and postoperative nutritional
management was decided on a case-by-case basis, the potential
superiority of low-fat elemental EN formula in early recovery
might be affected by such selection bias.
Finally, our results showed that early EN using low-fat elemental
formula after esophagectomy with three-ﬁeld lymphadenectomy
was safe and valid for postoperative recovery and could be poten-
tially useful for preventing chyle leak. A prospective randomized
control trial (RCT) will be necessary to elucidate the advantage of
early EN using low-fat elemental formula after esophagectomy
with three-ﬁeld lymphadenectomy for preventing chyle leak, and
we hope our present study provides a cornerstone for such future
clinical research.Source of funding
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